drugset / Trial / NCT01863706
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
RandomizedParallel-groupDouble-blindPrevention
Summary
Post partum Hemorrhage (PPH) is one of three main causes of death in pregnant women. Oxytocin is widely used for prevention of PPH. Some studies suggested misoprostol as an alternative treatment when Oxytocin isn't available. The aim of this study is to compare the safety and efficacy of Oxytocin and misoprostol for prevention of PPH.
Timeline
- Start
- 2013-05
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 400 ug | Oral |
| Comparator | Oxytocin | Peptide | 20 iu | — |
Indications
No indication recorded.